• EKSO

Earnings call: Ekso Bionics announces mixed Q3 results, eyes future growth

Ekso Bionics reported Q3 2024 sales of $4.1 million, facing challenges but optimistic about growth after achieving CMS reimbursement for its Ekso Indego Personal device.